DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $18.00 at Mizuho

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective cut by research analysts at Mizuho from $21.00 to $18.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Mizuho’s target price would indicate a potential upside of 17.92% from the stock’s previous close.

Several other equities research analysts also recently commented on the stock. Robert W. Baird lowered their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. UBS Group reduced their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Finally, Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Stock Performance

XRAY stock traded down $0.07 during trading on Thursday, reaching $15.27. The company had a trading volume of 150,573 shares, compared to its average volume of 2,558,490. The company has a market cap of $3.04 billion, a price-to-earnings ratio of -7.37, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA has a twelve month low of $15.04 and a twelve month high of $34.16. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a 50-day simple moving average of $18.35 and a 200-day simple moving average of $20.97.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.52% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several large investors have recently modified their holdings of the business. Colonial Trust Co SC acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth about $26,000. Riverview Trust Co acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB raised its stake in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares during the period. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares during the last quarter. Finally, Van ECK Associates Corp purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $42,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.